Virtus Investment Advisers’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $375K | Buy |
20,574
+1,344
| +7% | +$24.5K | 0.13% | 232 |
|
|
2025
Q1 | $382K | Buy |
19,230
+4,250
| +28% | +$84.3K | 0.1% | 215 |
|
|
2024
Q4 | $257K | Sell |
14,980
-62,917
| -81% | -$1.08M | 0.2% | 161 |
|
|
2024
Q3 | $1.56M | Buy |
+77,897
| New | +$1.56M | 1.22% | 13 |
|
|
2024
Q2 | – | Sell |
-157,268
| Closed | -$1.04M | – | 7 |
|
|
2024
Q1 | $1.04M | Hold |
157,268
| – | – | 0.74% | 31 |
|
|
2023
Q4 | $711K | Buy |
157,268
+84,373
| +116% | +$381K | 0.53% | 45 |
|
|
2023
Q3 | $261K | Buy |
72,895
+12,462
| +21% | +$44.6K | 0.18% | 141 |
|
|
2023
Q2 | $223K | Buy |
+60,433
| New | +$223K | 0.15% | 177 |
|